Treatment of gastrointestinal stromal tumor with imatinib mesylate: a retrospective single-center experience in Heidelberg

BACKGROUND: Gastrointestinal stromal tumor (GIST) is the most common mesenchymal neoplasm of the gastrointestinal tract. Surgery has been the only effective therapy. However, many patients still eventually die of disease recurrence. Chemotherapy and radiation therapy have been of limited value. Imat...

Full description

Saved in:
Bibliographic Details
Main Authors: Kasper, Bernd (Author) , Kallinowski, Birgit (Author) , Herrmann, Thomas (Author) , Lehnert, Thomas (Author) , Mechtersheimer, Gunhild (Author) , Geer, Thomas (Author) , Ho, Anthony Dick (Author) , Egerer, Gerlinde (Author)
Format: Article (Journal)
Language:English
Published: May 2006
In: Digestive diseases
Year: 2006, Volume: 24, Issue: 1/2, Pages: 207-211
ISSN:1421-9875
DOI:10.1159/000090322
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1159/000090322
Get full text
Author Notes:Bernd Kasper, Birgit Kallinowski, Thomas Herrmann, Thomas Lehnert, Gunhild Mechtersheimer, Thomas Geer, Anthony D. Ho, Gerlinde Egerer

MARC

LEADER 00000caa a2200000 c 4500
001 1776445120
003 DE-627
005 20230426232332.0
007 cr uuu---uuuuu
008 211109s2006 xx |||||o 00| ||eng c
024 7 |a 10.1159/000090322  |2 doi 
035 |a (DE-627)1776445120 
035 |a (DE-599)KXP1776445120 
035 |a (OCoLC)1341423427 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kasper, Bernd  |d 1974-  |e VerfasserIn  |0 (DE-588)12274764X  |0 (DE-627)082130736  |0 (DE-576)29340447X  |4 aut 
245 1 0 |a Treatment of gastrointestinal stromal tumor with imatinib mesylate  |b a retrospective single-center experience in Heidelberg  |c Bernd Kasper, Birgit Kallinowski, Thomas Herrmann, Thomas Lehnert, Gunhild Mechtersheimer, Thomas Geer, Anthony D. Ho, Gerlinde Egerer 
264 1 |c May 2006 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.11.2021 
520 |a BACKGROUND: Gastrointestinal stromal tumor (GIST) is the most common mesenchymal neoplasm of the gastrointestinal tract. Surgery has been the only effective therapy. However, many patients still eventually die of disease recurrence. Chemotherapy and radiation therapy have been of limited value. Imatinib mesylate (Glivec) is an orally administered competitive inhibitor of tyrosine kinases associated with the KIT, ABL protein, licensed for the treatment of metastatic GIST since 2002 in Germany. - METHODS: We summarized the data of 16 patients with advanced or metastatic GIST treated with imatinib mesylate in palliative and neoadjuvant settings. - RESULTS: Overall response was 81%, with no evidence of disease (NED) in 3/16 (19%), partial response (PR) in 9/16 (56%) and stable disease (SD) in 1/16 (6%), whereas 3/16 patients (19%) suffered from progressive disease (PD). Mean follow-up was 18.6 months [range: 4-30]. Mean progression-free survival (PFS) was 17.6 months [range: 0-30], mean overall survival (OS) from initial diagnosis was 32.3 months [range: 5-122]. Most common side effects were periorbital edema and skin rash. - CONCLUSION: Imatinib mesylate is well tolerated in a dose of up to 800 mg/day and has significant activity during long- term treatment of patients with advanced or metastatic GIST. 
650 4 |a Adult 
650 4 |a Aged 
650 4 |a Aged, 80 and over 
650 4 |a Antineoplastic Agents 
650 4 |a Benzamides 
650 4 |a Disease-Free Survival 
650 4 |a Female 
650 4 |a Follow-Up Studies 
650 4 |a Gastrointestinal Stromal Tumors 
650 4 |a Germany 
650 4 |a Humans 
650 4 |a Imatinib Mesylate 
650 4 |a Male 
650 4 |a Middle Aged 
650 4 |a Piperazines 
650 4 |a Protein-Tyrosine Kinases 
650 4 |a Pyrimidines 
650 4 |a Retrospective Studies 
650 4 |a Severity of Illness Index 
650 4 |a Survival Rate 
650 4 |a Treatment Outcome 
700 1 |a Kallinowski, Birgit  |d 1963-  |e VerfasserIn  |0 (DE-588)1116108402  |0 (DE-627)870566385  |0 (DE-576)478169698  |4 aut 
700 1 |a Herrmann, Thomas  |e VerfasserIn  |0 (DE-588)1235418685  |0 (DE-627)176045785X  |4 aut 
700 1 |a Lehnert, Thomas  |e VerfasserIn  |0 (DE-588)1076334229  |0 (DE-627)834714566  |0 (DE-576)445208724  |4 aut 
700 1 |a Mechtersheimer, Gunhild  |e VerfasserIn  |0 (DE-588)1021953024  |0 (DE-627)715842595  |0 (DE-576)170441598  |4 aut 
700 1 |a Geer, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Egerer, Gerlinde  |e VerfasserIn  |0 (DE-588)105502168X  |0 (DE-627)792516745  |0 (DE-576)167430882  |4 aut 
773 0 8 |i Enthalten in  |t Digestive diseases  |d Basel : Karger, 1985  |g 24(2006), 1/2, Seite 207-211  |h Online-Ressource  |w (DE-627)300191294  |w (DE-600)1482221-0  |w (DE-576)112438164  |x 1421-9875  |7 nnas  |a Treatment of gastrointestinal stromal tumor with imatinib mesylate a retrospective single-center experience in Heidelberg 
773 1 8 |g volume:24  |g year:2006  |g number:1/2  |g pages:207-211  |g extent:5  |a Treatment of gastrointestinal stromal tumor with imatinib mesylate a retrospective single-center experience in Heidelberg 
856 4 0 |u https://doi.org/10.1159/000090322  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211109 
993 |a Article 
994 |a 2006 
998 |g 105502168X  |a Egerer, Gerlinde  |m 105502168X:Egerer, Gerlinde  |d 910000  |d 910100  |e 910000PE105502168X  |e 910100PE105502168X  |k 0/910000/  |k 1/910000/910100/  |p 8  |y j 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 1021953024  |a Mechtersheimer, Gunhild  |m 1021953024:Mechtersheimer, Gunhild  |d 910000  |d 912000  |d 50000  |e 910000PM1021953024  |e 912000PM1021953024  |e 50000PM1021953024  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 5 
998 |g 1235418685  |a Herrmann, Thomas  |m 1235418685:Herrmann, Thomas  |d 50000  |e 50000PH1235418685  |k 0/50000/  |p 3 
998 |g 1116108402  |a Kallinowski, Birgit  |m 1116108402:Kallinowski, Birgit  |p 2 
998 |g 12274764X  |a Kasper, Bernd  |m 12274764X:Kasper, Bernd  |d 910000  |d 910100  |e 910000PK12274764X  |e 910100PK12274764X  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1776445120  |e 400001997X 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1776445120","origin":[{"dateIssuedDisp":"May 2006","dateIssuedKey":"2006"}],"name":{"displayForm":["Bernd Kasper, Birgit Kallinowski, Thomas Herrmann, Thomas Lehnert, Gunhild Mechtersheimer, Thomas Geer, Anthony D. Ho, Gerlinde Egerer"]},"person":[{"family":"Kasper","display":"Kasper, Bernd","given":"Bernd","role":"aut"},{"role":"aut","display":"Kallinowski, Birgit","given":"Birgit","family":"Kallinowski"},{"role":"aut","family":"Herrmann","given":"Thomas","display":"Herrmann, Thomas"},{"given":"Thomas","display":"Lehnert, Thomas","family":"Lehnert","role":"aut"},{"role":"aut","display":"Mechtersheimer, Gunhild","given":"Gunhild","family":"Mechtersheimer"},{"role":"aut","family":"Geer","given":"Thomas","display":"Geer, Thomas"},{"display":"Ho, Anthony Dick","given":"Anthony Dick","family":"Ho","role":"aut"},{"role":"aut","given":"Gerlinde","display":"Egerer, Gerlinde","family":"Egerer"}],"language":["eng"],"title":[{"subtitle":"a retrospective single-center experience in Heidelberg","title_sort":"Treatment of gastrointestinal stromal tumor with imatinib mesylate","title":"Treatment of gastrointestinal stromal tumor with imatinib mesylate"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1776445120"],"doi":["10.1159/000090322"]},"physDesc":[{"extent":"5 S."}],"relHost":[{"title":[{"title":"Digestive diseases","title_sort":"Digestive diseases"}],"corporate":[{"role":"isb","display":"European Association for Gastroenterology, Endoscopy and Nutrition"}],"origin":[{"dateIssuedDisp":"1985-","publisher":"Karger","publisherPlace":"Basel","dateIssuedKey":"1985"}],"note":["Gesehen am 16.09.25","Titelzusatz früher: current reviews in research and practice ; state-of-the-art clinical reviews"],"part":{"extent":"5","issue":"1/2","year":"2006","pages":"207-211","volume":"24","text":"24(2006), 1/2, Seite 207-211"},"id":{"zdb":["1482221-0"],"issn":["1421-9875"],"doi":["10.1159/issn.0257-2753"],"eki":["300191294"]},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"recId":"300191294","disp":"Treatment of gastrointestinal stromal tumor with imatinib mesylate a retrospective single-center experience in HeidelbergDigestive diseases","type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["Vol. 3, no. 4 (1985)-"]}],"note":["Gesehen am 09.11.2021"]} 
SRT |a KASPERBERNTREATMENTO2006